Chemokines/chemokine receptors play an important role in the continuum of acute to chronic lung allograft rejection

摘要

The finding of human and preclinical animal studies involving chemokine ligand/receptor biology may lead to therapeutic targets for this biology and interventions to reduce the incidence of acute and chronic (BOS) lung allograft rejection.